Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma.
Nat Commun
; 12(1): 7348, 2021 12 22.
Article
in En
| MEDLINE
| ID: mdl-34937871
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoadjuvant Therapy
/
Ipilimumab
/
Squamous Cell Carcinoma of Head and Neck
/
Nivolumab
/
Head and Neck Neoplasms
/
Immunotherapy
Type of study:
Clinical_trials
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2021
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
United kingdom